Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for CMV Infection
Phase of Trial: Phase IV
Latest Information Update: 18 Feb 2016
At a glance
- Drugs Cytomegalovirus immune globulin (Primary) ; Valganciclovir
- Indications Cytomegalic inclusion disorders
- Focus Therapeutic Use
- 12 Feb 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 14 May 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
- 28 Feb 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.